Current Practices in Hashimoto’s Thyroiditis: Differences in Attitudes Between Pediatric and Adult Endocrinologists in Türkiye: A National Survey
PDF

Original Article

Current Practices in Hashimoto’s Thyroiditis: Differences in Attitudes Between Pediatric and Adult Endocrinologists in Türkiye: A National Survey

J Clin Res Pediatr Endocrinol 2025;17(3):269-277 DOI: 10.4274/jcrpe.galenos.2025.2024-9-12
, , , , , ,
PDF
Permissions

Abstract

Objective

This study aimed to assess the clinical practices and attitudes towards Hashimoto’s thyroiditis (HT) among pediatric (PEs) and adult endocrinologists (AEs).

Methods

The members of Turkish Society for Pediatric Endocrinology and Diabetes (n=502) and the Society of Endocrinology and Metabolism of Türkiye (n=910) were invited to participate in an online survey.

Results

Of the respondents (n=168), 72.6% (n=122) were PEs and 27.3% (n=46) were AEs. The response rate was 24% among PEs and only 5% among AEs. Respondents median age was 41 years. The use of “only thyroid peroxidase autoantibodies” was preferred more frequently by AEs (28.3%) than by PEs (4.1%) (p=0.002). The rate of informing patient/parents at the time of diagnosis that HT lasts a lifetime was 91.3% for AEs and 62.3% for PEs (p=0.001). The rate of beginning treatment in euthyroid cases with goiter was significantly higher in PEs (26.2%) compared to AEs (4.3%) (p=0.017). Among AEs, 71.7% stated that they would never stop treatment, while among PEs, 33.6% did (p<0.001). Moreover, 44% of PEs stated that they would attempt treatment discontinuation in euthyroid patients at the end of puberty. The rate of those who were undecided about selenium supplementation was higher amongst PEs (41%) than among AEs (21.7%) (p=0.007). Although none of the PEs recommended gluten restriction, 6.5% of the AEs indicated that they would recommend gluten-free diet even without Celiac disease (p=0.015).

Conclusion

There are significant differences between PEs and AEs encompassing aspects of diagnosis, treatment and nutritional supplementation in HT.

Keywords: Adult endocrinology, attitude in management, Hashimoto’s thyroiditis, pediatric endocrinology, questionnaire

Read the full text

5 sections · 3 tables · 1 supplement · PDF

Create your free account to read the full text.

  • Full text with figures and tables
  • PDF and supplementary files
  • Access on every Galenos journal
Get free access

Already have an account?

Sign in
or
Continue with Google

One Galenos account works on every Galenos journal site.

References

1

Wasniewska MG, Gawlik AM, Aversa T. Editorial: autoimmune thyroid pathology-specificity of the pediatric age. Front Endocrinol (Lausanne). 2021;12:645278.

2

Hu X, Chen Y, Shen Y, Tian R, Sheng Y, Que H. Global prevalence and epidemiological trends of Hashimoto’s thyroiditis in adults: A systematic review and meta-analysis. Front Public Health. 2022;10:1020709.

3

McLachlan SM, Rapoport B. Why measure thyroglobulin autoantibodies rather than thyroid peroxidase autoantibodies? Thyroid. 2004;14:510-520.

4

Chiovato L, Vitti P, Santini F, Lopez G, Mammoli C, Bassi P, Giusti L, Tonacchera M, Fenzi G, Pinchera A. Incidence of antibodies blocking thyrotropin effect in vitro in patients with euthyroid or hypothyroid autoimmune thyroiditis. J Clin Endocrinol Metab. 1990;71:40-45.

5

Ralli M, Angeletti D, Fiore M, D’Aguanno V, Lambiase A, Artico M, de Vincentiis M, Greco A. Hashimoto’s thyroiditis: an update on pathogenic mechanisms, diagnostic protocols, therapeutic strategies, and potential malignant transformation. Autoimmun Rev. 2020;19:102649.

6

Wang SY, Tung YC, Tsai WY, Lee JS, Hsiao PH. Long-term outcome of hormonal status in Taiwanese children with Hashimoto’s thyroiditis. Eur J Pediatr. 2006;165:481-483. Epub 2006 Mar 24.

7

Demirbilek H, Kandemir N, Gonc EN, Ozon A, Alikasifoglu A. Assessment of thyroid function during the long course of Hashimoto’s thyroiditis in children and adolescents. Clin Endocrinol (Oxf). 2009;71:451-4.

8

Radetti G, Salerno M, Guzzetti C, Cappa M, Corrias A, Cassio A, Cesaretti G, Gastaldi R, Rotondi M, Lupi F, Fanolla A, Weber G, Loche S. Thyroid function in children and adolescents with Hashimoto’s thyroiditis after l-thyroxine discontinuation. Endocr Connect. 2017;6:206-212. Epub 2017 Mar 27.

9

Mazziotti G, Premawardhana LD, Parkes AB, Adams H, Smyth PP, Smith DF, Kaluarachi WN, Wijeyaratne CN, Jayasinghe A, de Silva DG, Lazarus JH. Evolution of thyroid autoimmunity during iodine prophylaxis--the Sri Lankan experience. Eur J Endocrinol. 2003;149:103-110.

10

Giassa T, Mamali I, Gaki E, Kaltsas G, Kouraklis G, Markou KB, Karatzas T. Iodine intake and chronic autoimmune thyroiditis: a comparative study between coastal and mainland regions in Greece. Hormones (Athens). 2018;17:565-571. Epub 2018 Sep 28.

11

Burek CL, Talor MV. Environmental triggers of autoimmune thyroiditis. J Autoimmun. 2009;33:183-189. Epub 2009 Oct 9.

12

Topliss DJ. Clinical update in aspects of the management of autoimmune thyroid diseases. Endocrinol Metab (Seoul). 2016;31:493-499.

13

Liontiris MI, Mazokopakis EE. A concise review of Hashimoto thyroiditis (HT) and the importance of iodine, selenium, vitamin D and gluten on the autoimmunity and dietary management of HT patients.Points that need more investigation. Hell J Nucl Med. 2017;20:51-56. Epub 2017 Mar 20.

14

Pirola I, Rotondi M, Cristiano A, Maffezzoni F, Pasquali D, Marini F, Coperchini F, Paganelli M, Apostoli P, Chiovato L, Ferlin A, Cappelli C. Selenium supplementation in patients with subclinical hypothyroidism affected by autoimmune thyroiditis: Results of the SETI study. Endocrinol Diabetes Nutr (Engl Ed). 2020;67:28-35. Epub 2019 Jun 10.

15

Shimizu Y, Noguchi Y, Sasaki N, Matsuu-Matsuyama M, Kawashiri SY, Yamanashi H, Arima K, Nakamichi S, Nagata Y, Hayashida N, Maeda T. Association between anti-thyroid peroxidase antibody and insufficient sleep in euthyroid population. Int J Clin Health Psychol. 2025;25:100565. Epub 2025 Apr 7.

16

Dhillon-Smith RK, Coomarasamy A. TPO antibody positivity and adverse pregnancy outcomes. Best Pract Res Clin Endocrinol Metab. 2020;34:101433. Epub 2020 Jun 18.

17

McLachlan SM, Rapoport B. Why measure thyroglobulin autoantibodies rather than thyroid peroxidase autoantibodies? Thyroid. 2004;14:510-520.

18

Tamaki H, Amino N, Kimura M, Hidaka Y, Takeoka K, Miyai K. Low prevalence of thyrotropin receptor antibody in primary hypothyroidism in Japan. J Clin Endocrinol Metab. 1990;71:1382-1386.

19

Diana T, Olivo PD, Kahaly GJ. Thyrotropin receptor blocking antibodies. Horm Metab Res. 2018;50:853-862. Epub 2018 Oct 4.

20

Younes YR, Perros P, Hegedüs L, Papini E, Nagy EV, Attanasio R, Negro R, Field BCT. Use of thyroid hormones in hypothyroid and euthyroid patients: A THESIS questionnaire survey of UK endocrinologists. Clin Endocrinol (Oxf). 2023;98:238-248. Epub 2022 Sep 16.

21

Lafontaine N, Brown SJ, Perros P, Papini E, Nagy EV, Attanasio R, Hegedüs L, Walsh JP. Use of thyroid hormones in hypothyroid and euthyroid patients: a survey of members of the Endocrine Society of Australia. Clin Endocrinol (Oxf). 2024;100:477-485. Epub 2024 Mar 11.

22

Svensson J, Ericsson UB, Nilsson P, Olsson C, Jonsson B, Lindberg B, Ivarsson SA. Levothyroxine treatment reduces thyroid size in children and adolescents with chronic autoimmune thyroiditis. J Clin Endocrinol Metab. 2006;91:1729-1734. Epub 2006 Feb 28.

23

Aksoy DY, Kerimoglu U, Okur H, Canpinar H, Karaağaoğlu E, Yetgin S, Kansu E, Gedik O. Effects of prophylactic thyroid hormone replacement in euthyroid Hashimoto’s thyroiditis. Endocr J. 2005;52:337-343.

24

Dörr HG, Bettendorf M, Binder G, Karges B, Kneppo C, Schmidt H, Voss E, Wabitsch M, Dötsch J. Levothyroxine treatment of euthyroid children with autoimmune Hashimoto thyroiditis: results of a multicenter, randomized, controlled trial. Horm Res Paediatr. 2015;84:266-274. Epub 2015 Aug 7.

25

Yoon SJ, Choi SR, Kim DM, Kim JU, Kim KW, Ahn CW, Cha BS, Lim SK, Kim KR, Lee HC, Huh KB. The effect of iodine restriction on thyroid function in patients with hypothyroidism due to Hashimoto’s thyroiditis. Yonsei Med J. 2003;44:227-235.

26

Çaylan N, Tezel B, Özbaş S, Şahin N, Aydın Ş, Acıcan D, Keskinkılıç B. Neonatal thyroid-stimulating hormone screening as a monitoring tool for iodine deficiency in Turkey. J Clin Res Pediatr Endocrinol. 2016;8:187-191. Epub 2016 Apr 18.

27

Vural M, Koc E, Evliyaoglu O, Acar HC, Aydin AF, Kucukgergin C, Apaydin G, Erginoz E, Babazade X, Sharifova S, Perk Y; Turkish Iodine Survey Group. Iodine status of Turkish pregnant women and their offspring: a national cross-sectional survey. J Trace Elem Med Biol. 2021;63:126664. Epub 2020 Oct 7.

28

Pobłocki J, Pańka T, Szczuko M, Telesiński A, Syrenicz A. Whether a gluten-free diet should be recommended in chronic autoimmune thyroiditis or not?-A 12-month follow-up. J Clin Med. 2021;10:3240.

29

Osowiecka K, Myszkowska-Ryciak J. The influence of nutritional intervention in the treatment of Hashimoto’s thyroiditis-a systematic review. Nutrients. 2023;15:1041.

30

Malandrini S, Trimboli P, Guzzaloni G, Virili C, Lucchini B. What about TSH and anti-thyroid antibodies in patients with autoimmune thyroiditis and celiac disease using a gluten-free diet? A systematic review. Nutrients. 2022;14:1681.

31

Winther KH, Papini E, Attanasio R, Negro R, Hegedüs L. A 2018 European Thyroid Association Survey on the use of selenium supplementation in Hashimoto’s thyroiditis. Eur Thyroid J. 2020;9:99-105. Epub 2020 Jan 14.

32

van Zuuren EJ, Albusta AY, Fedorowicz Z, Carter B, Pijl H. Selenium supplementation for Hashimoto’s thyroiditis. Cochrane Database Syst Rev. 2013;2013:CD010223.

33

Wichman J, Winther KH, Bonnema SJ, Hegedüs L. Selenium supplementation significantly reduces thyroid autoantibody levels in patients with chronic autoimmune thyroiditis: a systematic review and meta-analysis. Thyroid. 2016;26:1681-1692. Epub 2016 Nov 2.

34

Winther KH, Rayman MP, Bonnema SJ, Hegedüs L. Selenium in thyroid disorders - essential knowledge for clinicians. Nat Rev Endocrinol. 2020;16:165-176. Epub 2020 Jan 30.